News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Biotron.
RELATED STOCKHEAD STORIES
Health & Biotech
Health: Biotron’s anti-HIV therapy could mean patients may not need treatment forever
Health & Biotech
Gone viral: COVID-19 is making Jatenergy, AuMake so very rich
Health & Biotech
Your guide to COVID-19 vaccines: it’ll all be over soon
Health & Biotech
Dr Boreham’s Crucible: The small cap biotechs trying to make a buck from coronavirus
News
February Winners Column: Wannabe virus fighters ride high in a rough month for stocks
Health & Biotech
Here’s how to pick a successful drug out of the 99pc of failures
Health & Biotech
Dr Boreham’s Crucible: Cochlear can weather the coronavirus-induced China slump
Health & Biotech
Check up: Who’s in your coronavirus portfolio?
News
Lunchtime ASX small cap wrap: Who’s about to erupt today?
Health & Biotech
Health Kick Podcast: Coronavirus, HIV and hepatitis are in the sights of Aussie biotech Biotron
News
